- Doctor recommends
- Scheibenbogen, Kaufman
The CellTrend AutoAntibodyTest
Dr. Carmen Scheibenbogen, a German doctor and researcher, in collaboration with Celltrend - a German lab - have produced an auto-antibody test for ME/CFS which assesses the levels of three auto-antibodies against the b2-adrenergic receptor, the muscarinic cholinergic receptor 3 (M3) and the muscarinic cholinergic receptor 4 (M4).
One study suggests that from 20-30% of ME/CFS patients have elevated levels of these auto-antibodies. Dr. Kaufman recently reported that he's had success using the Celltrend test to determine which patients benefit from Rituximab.
Dr. Scheibenbogen
Through it's Ramsay Awards the Solve ME/CFS Initiative (SMCI) funded Dr. Scheibenbogen's work in 2016 and 2017.
In a small ME/CFS trial Dr. Scheibenbogen found success using a process called Immunoadsorption to reduce the autoantibody levels.
Learn more about Dr. Scheibenbogen's work in ME/CFS
Dr. Carmen Scheibenbogen, a German doctor and researcher, in collaboration with Celltrend - a German lab - have produced an auto-antibody test for ME/CFS which assesses the levels of three auto-antibodies against the b2-adrenergic receptor, the muscarinic cholinergic receptor 3 (M3) and the muscarinic cholinergic receptor 4 (M4).
One study suggests that from 20-30% of ME/CFS patients have elevated levels of these auto-antibodies. Dr. Kaufman recently reported that he's had success using the Celltrend test to determine which patients benefit from Rituximab.
Dr. Scheibenbogen
Through it's Ramsay Awards the Solve ME/CFS Initiative (SMCI) funded Dr. Scheibenbogen's work in 2016 and 2017.
In a small ME/CFS trial Dr. Scheibenbogen found success using a process called Immunoadsorption to reduce the autoantibody levels.
Learn more about Dr. Scheibenbogen's work in ME/CFS
![ME/CFS lecture | Dr Nancy Klimas | 2011 [Chronic Fatigue Syndrome / SEID / New Zealand] - YouTube](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
